STOCKS IN THIS STORY
(Bloomberg) -- Philip Morris International Inc. is raising its bid for the U.K. asthma drug maker Vectura Group Plc to 165 pence apiece, the company announced on Sunday.
The increased offer values Vectura's shares at about GBP1.02 billion, according to an emailed statement.
NOTE, from Aug 6: Carlyle Raises Offer for Vectura, Elbowing Out Philip Morris
©2021 Bloomberg L.P.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
